arrow
A

Akira Fujita

Niigata University
H指数:31
被引数:3,685

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Impact of the preoperative modified 5-item frailty index on the efficacy of neoadjuvant chemotherapy in patients with muscle invasive bladder cancer

Goto, K.; Kohada, Y.; Kobatake, K.; Tasaka, R.; Iwamoto, H.; Ueno, T.; Fujita, A.; Furutani, T.; Hashimoto, K.; Kurimura, Y.; et al. 术前改良5项脆弱性指数对肌肉浸润性膀胱癌患者新辅助化疗疗效的影响。Urol. Oncol. Semin. Orig. Investig. 2025, 43, 695.e11–695.e19. [Google Scholar] [CrossRef]

2025-11-011
OAAI
Modified Glasgow prognostic score predicts outcomes of tyrosine kinase inhibitor monotherapy and immune checkpoint inhibitor combination therapy for metastatic renal cell carcinoma

改良版格拉斯哥预后评分可预测转移性肾细胞癌的酪氨酸激酶抑制剂单药治疗和免疫检查点抑制剂联合治疗的疗效。

2025-09-010
OAAI
Real-World Survival Outcomes of Partial Versus Radical Nephrectomy: Cause-Specific and Time-Dependent Effects

Kohada, Y.; Shikuma, H.; Goto, K.; Akiyama, K.; Kajiwara, M.; Matsuzaki, S.; Fujita, A.; Nishida, K.; Tasaka, R.; Miyamoto, S.; et al. 部分肾切除术与根治性肾切除术的真实世界生存结局:病因特异性和时间依赖性效应。Clin. Genitourin. Cancer 2025, 23, 102391. [Google Scholar] [CrossRef] [PubMed]

2025-09-011
OAAI
Senescence in palatal rugae development

腭皱襞发育中的衰老

2025-08-120
PRE
Treatment outcomes with radium-223 in patients with metastatic castration-resistant prostate cancer with bone metastasis in real-world practice: a multiinstitutional study

应用镭-223治疗伴有骨转移的转移性去势抵抗性前列腺癌患者的真实世界疗效:一项多中心研究

2025-03-240
OAAI
Cell-cell interaction determines cell fate of mesoderm-derived cell in tongue development through Hh signaling
2024-10-110
OA
Mycobacterium kyorinense Infection
2013-03-019
OAAI